"Dihydroergotamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically for the therapy of MIGRAINE DISORDERS.
| Descriptor ID |
D004087
|
| MeSH Number(s) |
D03.132.327.412.225 D03.633.400.562.300
|
| Concept/Terms |
DHE-45- DHE-45
- DHE 45
- DHE45
- D.H.E. 45
Dihydroergotamine Mesylate- Dihydroergotamine Mesylate
- Mesylate, Dihydroergotamine
- Dihydroergotamine Methanesulfonate
- Methanesulfonate, Dihydroergotamine
Migranal- Migranal
- Dihydergot
- Dihydroergotamine-Sandoz
- Dihydroergotamine Sandoz
|
Below are MeSH descriptors whose meaning is more general than "Dihydroergotamine".
Below are MeSH descriptors whose meaning is more specific than "Dihydroergotamine".
This graph shows the total number of publications written about "Dihydroergotamine" by people in this website by year, and whether "Dihydroergotamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dihydroergotamine" by people in Profiles.
-
Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors. Sci Rep. 2020 02 18; 10(1):2851.
-
Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia. Leukemia. 2019 01; 33(1):52-63.
-
Increased rate of venous thrombosis may be associated with inpatient dihydroergotamine treatment. Neurology. 2017 Jul 18; 89(3):279-283.
-
Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine. Headache. 2016 Jan; 56(1):153-61.
-
Dihydroergotamine as a pharmacologic euglycemic clamp in the surgically traumatized rabbit. Metabolism. 1991 Jun; 40(6):594-9.
-
Vascular spasm during heparin-dihydroergotamine prophylaxis. Clin Pharm. 1987 Jul; 6(7):575-7.
-
Uropharmacology: XI. Adrenergic-blocking agents and drugs affecting catecholamine binding and release. Urology. 1979 Jun; 13(6):693-700.
-
Aggregation of blood platelets by adrenaline and its uptake. Biochem Pharmacol. 1975 Oct 15; 24(20):1903-4.